Clinical and Vaccine Trials for COVID-19: Key Considerations from Social Science
MetadataShow full item record
Previous months have witnessed a growth of clinical research in response to the COVID-19 crisis. This brief sets out social science considerations that can inform clinical and vaccine trials for COVID-19. It was developed for SSHAP by London School of Hygiene and Tropical Medicine (LSHTM) by Rose Burns, Alex Bowmer, Luisa Enria, Samantha Vanderslott (University of Oxford) and Shelley Lees in order to inform design, recruitment and community engagement, implementation and results dissemination for trials of emerging vaccine and therapeutic candidates for COVID-19. Colleagues from Dalhousie University and Kings college London reviewed it.Please note: there is an accompanying infographic summarising the key points from the briefing.
CitationSSHAP (2020) Clinical and Vaccine Trials for COVID-19: Key Considerations from Social Science (October 2020), SSHAP